Revenue (USD, millions)

Cost of revenue (USD, millions)

Gross profit (USD, millions)

Operations and support (USD, millions)

Research and development (USD, millions)

Sales and marketing (USD, millions)

General and administrative (USD, millions)

Total operating expenses (USD, millions)

Income (loss) from operations (USD, millions)

Other expense, net (USD, millions)

Interest income (USD, millions)

Income (loss) before provision for (benefit from) income taxes (USD, millions)

Provision for (benefit from) income taxes (USD, millions)

Net income (loss) (USD, millions)

Accretion related to Series A redeemable convertible preferred stock (USD, millions)

Net income (loss) attributable to common stockholders, basic (USD, millions)

Net income (loss) attributable to common stockholders, diluted (USD, millions)

Net income (loss) per share attributable to common stockholders, basic (USD)

Net income (loss) per share attributable to common stockholders, diluted (USD)

Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic (thousands)

Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted (thousands)

0743c377d8ee8caa4f9f3186ac575ee4feb345ee8a8bd888ac644905c0bd66af

Net income (loss) [USD, millions]

Depreciation and amortization expense [USD, millions]

Stock-based compensation expense [USD, millions]

Provision for bad debts [USD, millions]

Amortization of operating lease right-of-use assets [USD, millions]

Other, operating activities [USD, millions]

Net cash provided by operating activities [USD, millions]

Purchases of marketable securities [USD, millions]

Maturities of marketable securities [USD, millions]

Purchases of property and equipment, including capitalized internal-use software [USD, millions]

Other investing activities [USD, millions]

Net cash provided by (used in) investing activities [USD, millions]

Taxes paid related to net share settlement of equity awards [USD, millions]

Proceeds from exercise of stock options [USD, millions]

Repurchases of common stock [USD, millions]

Net cash provided by (used in) financing activities [USD, millions]

Effect of foreign exchange on cash, cash equivalents, and restricted cash and cash equivalents [USD, millions]

Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents [USD, millions]

Deferred income taxes [USD, millions]

Cash, cash equivalents, and restricted cash and cash equivalents - beginning of period [USD, millions]

Cash, cash equivalents, and restricted cash and cash equivalents - end of period [USD, millions]

fcfc5997de2499877db77b53ec1531e0defd9503f3ab64930b096935482e9d9f

The marked decline in cash and cash equivalents in Q3 2024—from **$2,137 million** at year-end 2023 to **$1,288 million**—was primarily driven by a **share repurchase program** that cost **$1,402 million** for the repurchase and retirement of **46 million common shares**. In addition, operational factors such as variability in cash flows from operating activities, irregularities in working capital, and the timing of payments to various stakeholders further contributed to the reduction in cash. This combination of significant outflows due to capital return activities and operating cash flow fluctuations led to the marked drop in cash and cash equivalents in Q3 2024.  **[0001579091-24-000103_cart-20240930.htm:5]** **[0001579091-24-000103_cart-20240930.htm:56]** **[0001579091-24-000099_cartthirdquarter2024shar.htm:11]** 

Why did cash and cash equivalents drop so markedly in Q3 2024?

The decline in total assets in Q3 2024 was primarily driven by a **reduction in cash and cash equivalents** (a drop of **$849 million**, from **$2,137 million** to **$1,288 million**), along with decreases in **short-term marketable securities** (down **$29 million**, from **$49 million** to **$20 million**), **deferred tax assets** (down **$55 million**, from **$830 million** to **$775 million**), and **prepaid expenses and other current assets** (down **$11 million**, from **$129 million** to **$118 million**). These declines were only partially offset by an increase in **property and equipment, net** (from **$135 million** to **$192 million**).  **[0001579091-24-000103_cart-20240930.htm:5]** 

What factors drove the decline in total assets in Q3 2024?

Total liabilities rose in Q3 2024 primarily because of an increase in accrued and other current liabilities (up by **$79 million**) and deferred revenue (up by **$12 million**), partially offset by a decrease in operating lease liabilities (down by **$12 million**), resulting in a net increase of **$70 million** compared to FY 2023 figures.  **[0001579091-24-000103_cart-20240930.htm:5]** **[0001579091-24-000099_cartthirdquarter2024shar.htm:11]** 

Why did total liabilities rise in Q3 2024?

f7aac1ff8fde14c897aeabb3da28c77e956f5087437a58fd4248b218b92887a6

Cash and cash equivalents (USD, millions)

Short-term marketable securities (USD, millions)

Accounts receivable, net of allowance (USD, millions)

Restricted cash and cash equivalents, current (USD, millions)

Prepaid expenses and other current assets (USD, millions)

Total current assets (USD, millions)

Restricted cash and cash equivalents, noncurrent (USD, millions)

Property and equipment, net (USD, millions)

Operating lease right-of-use assets (USD, millions)

Intangible assets, net (USD, millions)

Goodwill (USD, millions)

Deferred tax assets, net (USD, millions)

Other assets (USD, millions)

Total assets (USD, millions)

Accounts payable (USD, millions)

Accrued and other current liabilities (USD, millions)

Operating lease liabilities, current (USD, millions)

Deferred revenue (USD, millions)

Total current liabilities (USD, millions)

Operating lease liabilities, noncurrent (USD, millions)

Other long-term liabilities (USD, millions)

Total liabilities (USD, millions)

Series A redeemable convertible preferred stock (USD, millions)

Preferred stock (USD, millions)

Common stock (USD, millions)

Additional paid-in capital (USD, millions)

Accumulated other comprehensive income (loss) (USD, millions)

Accumulated deficit (USD, millions)

Total stockholders’ equity (USD, millions)

Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (USD, millions)

a1fc39e4e657dc2967f9796f288b068e0337b6100883b6c490957f33d17fddce

United States

International

Total Revenue

b8e843606ff33142b6a2d8c84321fd4a25f90b5a95bd9f7b4789cd622579c06c

Adjustments for Non-Cash Items (USD, millions)

Stock-Based Compensation (USD, millions)

Changes in Working Capital (USD, millions)

Capital Expenditures (CapEx) (USD, millions)

Proceeds from / Repayments of Debt (USD, millions)

Share Repurchases (USD, millions)

Dividend Payments (USD, millions)

Net Change in Cash (USD, millions)

4c10ff46c5c2963274cbd637c58b308452719b9509edeb9eb046e87da60767f5

Total Revenue (USD, millions)

Cost of Goods Sold (COGS) (USD, millions)

Selling, General, and Administrative Expenses (SG&A) (USD, millions)

Research and Development (R&D) (USD, millions)

Depreciation and Amortization (D&A) (USD, millions)

Interest Expense (USD, millions)

Operating Income (EBIT) (USD, millions)

Net Income (USD, millions)

Earnings Per Share (EPS) - Basic (USD)

Earnings Per Share (EPS) - Diluted (USD)

68cb12cc9988f9554f2bccc82d9f9f9a6a0fa083adc8fc028cc3563cb58b2fcb

Current Assets (USD, millions)

Cash and Cash Equivalents (USD, millions)

Accounts Receivable (USD, millions)

Inventory (USD, millions)

Non-Current Assets (USD, millions)

Property, Plant, and Equipment (PP&E) (USD, millions)

Intangible Assets (USD, millions)

Current Liabilities (USD, millions)

Accounts Payable (USD, millions)

Short-term Debt (USD, millions)

Accrued Expenses (USD, millions)

Non-Current Liabilities (USD, millions)

Lease Liabilities (USD, millions)

Deferred Tax Liabilities (USD, millions)

Shareholders' Equity (USD, millions)

Retained Earnings (USD, millions)

Common Stock (USD, millions)

Additional Paid-in Capital (USD, millions)

5edfff89eb189465908223c3a3e63ddd3b888bdfd4244ddded57bb5df2f5d31f

Number of orders (millions)

Gross Transaction Value (GTV) (USD millions)

277155d33d273fc05f6d8433cf18899b3596e7f4393c7f11dee1589a3b77dc80

Transaction

Advertising and Other

d85f80409a1470389375026eb111c41eb31348bac76565fe0fb401b753346f7f

Maplebear (CART)

Financials